Clinical Trials
31
Active:23
Completed:4
Trial Phases
3 Phases
Phase 1:21
Phase 3:1
Not Applicable:7
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (31 trials with phase data)• Click on a phase to view related trials
Phase 1
21 (67.7%)Not Applicable
7 (22.6%)phase_1_2
2 (6.5%)Phase 3
1 (3.2%)No trials found
News
Commit Biologics Forms Scientific Advisory Board to Advance Complement-Based Cancer and Autoimmune Therapies
Commit Biologics has established a Scientific Advisory Board co-chaired by antibody expert Janine Schuurman and CEO Mikkel Wandahl Pedersen to guide development of its BiCE™ complement activation platform.
ERS Congress 2024 Addresses Critical Ethical Challenges of AI in Clinical Decision-Making
The European Respiratory Society Congress 2024 highlighted key ethical principles for AI integration in healthcare, including patient autonomy, beneficence, and the need for explainable AI systems.